SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros Corp is experiencing significant buzz following FDA approval for YARTEMLEA, its groundbreaking treatment for TA-TMA, which also includes pediatric use. The community is buzzing with excitement over its "first and only" approved status, anticipating a substantial re-rating and potential short squeeze, with many long-term holders eyeing significant upside and a possible buyout by NVO. Despite some discussions around potential profit-taking, a strong sense of long-term value and market opportunity prevails among investors.

Keeta is a high-performance layer-1 blockchain designed to unify transactions across different blockchains and fiat payment systems, eliminating the need for costly intermediaries, reducing fees, and enabling near-instant settlements. With 400-millisecond transaction finality and the ability to process 10 million transactions per second, Keeta sets a new industry benchmark for speed and scalability.  Founded in 2022 and backed by Eric Schmidt, the former CEO of Google, Keeta has been engineered to meet the stringent regulatory and operational requirements of financial institutions. Its advanced on-chain compliance protocols, including KYC and AML, ensure security and regulatory adherence. Keeta’s architecture natively supports asset tokenization and digital identity, making it an ideal platform for stablecoins and real-world asset transfers.  By facilitating cross-chain transactions and interoperability with existing payment systems, Keeta bridges the gap between cryptocurrencies and fiat, enabling a secure, efficient, and compliant global financial ecosystem.

Keeta

Keeta (KTA CRYPTO) is trending as a potentially undervalued infrastructure play, with its compliance-first architecture and impressive throughput of over 11 million transactions per second positioning it as critical global financial plumbing. The community is actively discussing its live integration with Bridge, a Stripe-owned fiat anchor, enabling seamless transfers between traditional banking and crypto for institutional flows. This makes KTA an early-stage opportunity for those seeking exposure to the future of financial systems.

Yee is a community based memecoin with one mission: to fight Pepe again. Made to honor the iconic meme rivalry we all know and love.  The Yee Legend  [Filed by: Yee’s Archivist & Legal Representative]  There’s something the meme world refuses to talk about: Pepe the Frog stole Yee the Dino’s entire launch plan.  Yee had been preparing for his comeback for months, but Pepe launched two weeks earlier, hijacking Yee’s concept and selling it as his own.  The charges? Meme theft, intellectual forgery, and historical erasure.  Yee’s official contract was filed in April 2023, right after Pepe’s surprise drop. This wasn’t timing—it was theft. The archives are about to open, and history is about to be corrected

Yee Token

Yee Token ($YEE) is generating significant buzz and upward momentum, with the community actively celebrating notable price appreciation and continuous gains. Enthusiasts are rallying around an "unfolding prophecy" and "ETH season" narrative, firmly positioning $YEE as a compelling, generational meme coin to "study" and accumulate during market pullbacks.

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

Greenwich LifeSciences Inc

Greenwich LifeSciences is trending due to groundbreaking preliminary data from its FLAMINGO-01 trial, showing an impressive approximately 80% reduction in breast cancer recurrence rates, a development the community views as a significant de-risking event for the immunotherapy. This positive clinical update, coupled with an exceptionally high cost-to-borrow rate and a very low share float, is fueling intense investor speculation about an imminent short squeeze and potential strategic partnerships, as insiders continue to demonstrate strong conviction through share accumulation.

AMC Robotics Corp. engages in developing and deploying AI-enabled robotics and smart security solutions, especially for warehouse automation, enterprise security, robotics patrol/incident-response and logistics automation. The company is headquartered in New York, NY.

AMC Robotics Corp.

AMCI is trending amid strong community buzz, driven by discussions surrounding its notably low public float and the potential for a short squeeze following recent significant market activity. Many are highlighting that a substantial portion of shares are locked up for months, suggesting minimal dilution risk and drawing comparisons to other volatile low-float runners within the active Robotics/AI sector. Traders are actively debating market manipulation narratives alongside calls to hold for further upward momentum, especially as attention focuses on warrant exercisability in the coming weeks.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is trending after Apple CEO and board member Tim Cook's notable open-market purchase of its shares, which many in the community are interpreting as a strong vote of confidence. This insider buying has ignited conversations about a potential turnaround and short squeeze for the stock, which has recently faced headwinds from China sales and tariff concerns.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is a top trending stock following the landmark FDA approval of its oral Wegovy pill, a major development set to revolutionize the weight-loss market by offering a convenient, needle-free treatment option. The community is buzzing with optimism, anticipating significant long-term growth and market share expansion for NVO in the rapidly expanding GLP-1 sector, despite competitive dynamics.

Dynavax Technologies Corp. is a biopharmaceutical company, which engages in the provision of discovery, development, and commercialization of novel vaccines and immuno-oncology therapeutics. Its product includes HEPLISAV-B, which prevents infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Emeryville, CA.

Dynavax Technologies Corp.

Dynavax Technologies is trending after Sanofi's definitive agreement to acquire the company for $15.50 per share in cash, representing a significant premium. This move bolsters Sanofi's adult immunization portfolio with Dynavax's Heplisav-B and a promising shingles vaccine candidate. The community is actively debating the acquisition price, with many long-term shareholders expressing disappointment and some speculating on the possibility of a higher bid.

Frequency Electronics, Inc. engages in the design, development, and manufacture of precision time and frequency generation technology. It operates through the FEI-NY and FEI-Zyfer business segments. The FEI-NY segment provides precision time, frequency generation, and synchronization products and subsystems that are found on-board satellites, in ground-based communication stations, and imbedded in moving platforms. The FEI-Zyfer segment designs, develops, and manufactures products for precision time and frequency generation and synchronization, primarily incorporating GPS technology. The company was founded by Martin B. Bloch on August 25, 1961 and is headquartered in Uniondale, NY.

Frequency Electronics, Inc.

Frequency Electronics is a top discussion point following strong Q2 sales and a record backlog, with the CEO hinting at significant upcoming contracts in quantum sensing and defense. The community actively highlights its critical role in initiatives like the Golden Dome and its low float, driving bullish price expectations as an underfollowed gem.

Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in a research engine, multiple novels, and investigational therapies in preclinical development. It focuses on cellular metabolism and classical hematology. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.

Agios Pharmaceuticals Inc

Agios Pharmaceuticals is trending following recent FDA approval of AQVESME for anemia in adults with alpha- or beta-thalassemia, marking it as the only approved therapy for this rare blood disorder. The community is expressing significant optimism, anticipating upward movement as this decision broadens the company's therapeutic offerings. This development is driving conversations around the stock's potential within the rare disease sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

MIAMI, May 21, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 82nd Emerging Growth Conference on May 21 &amp; 22, 2025.The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products &amp; services, focused strategy, execution, and the overall potential for long-term growth.<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=EbOWqh8i53PXrwNlmG0Wlv_ppcrooXY9gGGN-pmvbQsHP9Dy9zxKHcxPfUjl1q9Ecxa3oyi1-6Ovay6xvfn789unux0OcG0fqP_asO9e3CSXIFflEvbbHEkkqhRcCSyZYh8ZDddVtPCT0D5HIszqDqu1Zm4NKA3cpuaDrKAlBbQ4jYP9aV7Nt1jPY1i_I9gI">Register for the Conference here.</a>Submit Questions for any of the presenting companies to:&nbsp; <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=kVS7sRiC5r3pmKmmLmcnFfKVHwn3ForBjHdEL_DkjcAdSa7Vfl49Vmps4dZXZnR3R1AllwAIK6zplkM63tKkp1bl6U36BmbuKFnRAn9_bd0bE6Eoh-CVgzqqSw0wBQP7">Questions@EmergingGrowth.com</a>For updates, <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=QyoNQ3EHdryQlOSsMA6n-naij0y67SP9RKqot4s4-sGqcJevbJZfdMFD3-e24k-Bq0SWVBj1RsK7zMrMYt3PEW5x_B9Mu003Ab1rFrMgkKbuA-WGNCZdEJAvfT-JhRBa">follow us on Twitter</a>Day 1 – Presenting Today, May 21, 20258:45 Virtual Lobby opens. <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=EbOWqh8i53PXrwNlmG0Wlv_ppcrooXY9gGGN-pmvbQsCtCEaOWn5mCiO23xzl5Xj94vjJcI0-QljrHizBLlj5RRBSojDiBqMUAAO43qk4UXYQe2rCcfn2q0zt869_6p6zBXqnVRmTt8JBiM0bPtfa1DtQ9--5ogE1sPyxzN9U4OLTe4JVo5Hn0STsOKOC5o0">Register for the Conference.</a>&nbsp;If you already registered, go back to the registration link and click “Already registered” and enter your email.9:00 Introduction9:05 – 9:35 Aurora Mobile Limited (NASDAQ: JG) Keynote speaker: Shan-Nen Bong, CFOPostponed to June 17 ASP Isotopes Inc. (NASDAQ: ASPI) Keynote speaker: Paul Elliot Mann, CEO10:15 – 10:45 HeartSciences, Inc. (NASDAQ: HSCS)&nbsp; Keynote speaker: Andrew Simpson, President / CEO11:25 - 11:55 Thumzup Media Corporation (NASDAQ: TZUP) Keynote speaker: Robert Steele, CEO12:00 – 12:30 22nd Century Group, Inc. (NASDAQ: XXII) Keynote speaker: Lawrence D. Firestone, Chairman &amp; CEO1:10 – 1:40 Medicenna Therapeutics Corp. (OTCQX: MDNAF) (TSX: MDNA) Keynote speaker: Fahar Merchant, President and CEOPostponed to June Conference Sono Group N.V. (OTCQB: SEVCF) Keynote speaker: George O’Leary, Managing Director, CEO and CFO2:55 – 3:05 NCS Multistage Holdings, Inc. (NASDAQ: NCSM) Keynote speaker: Ryan Hummer, CEO &amp; Director3:10 - 3:20 Clene Inc., (NASDAQ: CLNN) Keynote speakers: Rob Etherington, President / CEO3:25 - 3:35 Interstellar Communication Holdings Keynote speakers: Seda Hewitt, Space Ambassador of IcMercury Harri Laitinen, Lifeguard of IcMercury, and Lijie Zhu, Captain of IcMercury3:40 – 3:50 Touchstone Explorations, Inc. (OTC Pink: PBEGF) (TSX: TXP) Keynote speaker: Paul Raymond Baay, President &amp; CEO4:10 – 4:20 Citizens, Inc. (NYSE: CIA) Keynote speakers: Jon Stenberg, President / CEO, and Jeff Conklin, CFO4:25 - 4:35 MetaVia, Inc. (NASDAQ: MTVA) Keynote speakers: Hyung Heon “HH” Kim, President / CEO, &amp; Marshall H. Woodworth, CFO _______________________________________________________________Day 2 – Presenting Tomorrow, May 22, 20258:45 Virtual Lobby opens. <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=EbOWqh8i53PXrwNlmG0Wlv_ppcrooXY9gGGN-pmvbQu7PXLRYq49yKICWecEGDrFt2jSl2mK6BAJbvHIayyZIvCsoKppGsv7tyFtfFK6sa6v2JLC-iMB27xVDvue-fZ7Olg3FVgJlhrNLEvIgGsmmuC2kOrAG-TFl8R9lX8qNXH0gQZjb6wdmmXG8OD8hWw-">Register for the Conference.</a>&nbsp;If you already registered, go back to the registration link and click “Already registered” and enter your email.9:00 Introduction9:05 – 9:35 TNL Mediagene’s (NASDAQ: TNMG)&nbsp; Keynote speaker: Joey Chung, Co-Founder &amp; CEOPostponed to the June Conference Jaguar Health, Inc. (NASDAQ: JAGX) Keynote speaker: Lisa A. Conte, Founder, CEO, President &amp; Director10:15 – 10:45 Onfolio Holdings, Inc. (NASDAQ: ONFO) Keynote speaker: Dominic Wells, CEO10:50 – 11:20 Rackla Metals Inc. (OTC Pink: RMETF) (TSX-V: RAK) Keynote speaker: Simon T. P. Ridgway, Chairman &amp; CEO11:25 – 11:35 Bioxytran, Inc. (OTCQB: BIXT) Keynote speakers: Dr. David Platt, CEO &amp; Mike Sheikh, Executive Vice President Business Development12:00 – 12:30 AtlasClear Holdings, Inc. (NYSE: ATCH)&nbsp; Keynote speakers: Craig Ridenhour, President &amp; John Schaible, Chairman and CEO12:35 – 1:05 Faraday Future Intelligent Electric, Inc. (NASDAQ: FFAI) Keynote speakers: Jerry Wang, Global President1:10 – 1:40 Vizsla Royalties Corp. (TSXV: VROY) (OTCQB: VROYF) Keynote speaker: Michael N. Pettingell, President and CEO1:45 - 2:15 Wytec International, Inc. (OTCQB: WYTC) Keynote speaker: William Gray, CEO, CFO2:20 – 2:50 Zyppah Keynote speaker: Dr. Jonathan Greenburg, founder and owner, &amp; Larry Biggs, CEO2:55 – 3:05 Ucore Rare Metals, Inc. (OTCQX: UURAF) (TSXV: UCU) Keynote speakers: Pat Ryan, CEO3:10 - 3:20 Regen BioPharma Inc. (OTC Pink: RGBP) Keynote speakers: David Koos, President / CEO, &amp; Harry M. Lander, Ph.D. Senior Scientific Consultant3:25 – 3:35 Monumental Energy Corp. (OTCQB: MNMRF) (TSXV: MNRG) Keynote speaker: Maximilian Sali, VP Corporate Development, Founder &amp; Director3:40 – 3:50 HydroGraph Clean Power Inc. (OTCQB: HGRAF) (CSE: HG) Keynote speaker: Kjirstin Breure, President and CEO3:55 – 4:05 West Red Lake Gold Mines Ltd. (OTCQB: WRLGF) (TSXV: WRLG) Keynote Speaker: Gwen Preston, Vice President, Communications4:10 – 4:20 XBP Europe Holdings, Inc. (NASDAQ: XBP)&nbsp; Keynote speaker: Andrej Jonovic, CEO &amp; Director4:25 – 4:35 Gossamer Bio, Inc. (NASDAQ: GOSS) Keynote speaker: Bryan Giraudo, CFO &amp; COO4:40 – 4:50 Highland Copper Company Inc. (OTCQB: HDRSF) (TSXV: HI) Keynote speaker: Barry O’Shea, CEOVisit the following link to register. You will then receive an email containing the link and time to sign into the conference.<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=EbOWqh8i53PXrwNlmG0Wlv_ppcrooXY9gGGN-pmvbQticY_xllLbbXDdJzBnThtCgpzeG1RreUN9uOWWzEzGFDrv_EioYkwLh3YKkit05u_zoeukNoAon6bIDsEg59jdviZArnXg17V9qHcd-NwkSN1H3Ck8RNMJitlywH2ewmi2dUe_513vxvnzu8nZgVoH">Register for the Conference here.</a>Submit Questions for any of the presenting companies to:&nbsp; <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=kVS7sRiC5r3pmKmmLmcnFfKVHwn3ForBjHdEL_DkjcCXWt1jEcdouclrAjUDONNi0vjFTY2TzEicQe757ZBgD4zn4aIBRFrMSpQVCfPE9U8-k3_hxxQu7O-FCtuf3pYz">Questions@EmergingGrowth.com</a>Replays: <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=z2Fwu4AR6GcKiqmUvMmGxOvS5RTh-ZTPtR1p5DdIsuIwVjZ85Xoj6Os0MZbBcOSPqn0U9BXgLipCq376rJX0i-AO7CPfsFFyky-Hcw64TQAsdxfFrbB_pKw2gTc7xeqGm-2ZWxk62kK2wGlgLna1oA==">Subscribe to our YouTube Channel</a>About&nbsp;EmergingGrowth.comFounded in 2009, Emerging Growth.com quickly became a leader in its space and has developed an extensive history of identifying emerging growth companies that can be overlooked by the investment community.About the Emerging Growth ConferenceThe Emerging Growth Conference is an effective way for public companies to engage with the investment community regarding their Company, new products, services and other major announcements from anywhere, in an effective and time efficient manner.All sessions are conducted through video webcasts. Our conference serves as a vehicle for Emerging Growth to build relationships with our existing and potential clients. Accordingly, a certain number of the presenting companies are our current clients, and some may become our clients in the future. In exchange for services we provide, our clients pay us fees in the form of cash and securities, and we may currently have, or in the future may have investments in the securities of certain of the presenting companies. Finally, certain of the presenting companies have paid us a fee to secure a presentation time slot or to present generally. The presentations to be delivered by the presenting companies (including any virtual handouts of written materials) have not been approved, endorsed by or otherwise reviewed by&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=GQlkz4IPN52hqcN02CUC-y8Tp54nzgA0ovKGjy1JW3GrXlwtcyD0IGmti_UZw_LBQDX-MyrQ-PpCsSJ0rXrbQ49Sl6Q1-eNMU6DTfywB5UE=">EmergingGrowth.com</a>&nbsp;nor should they in any way be construed to have been made in connection with an offer to sell or a solicitation of an offer to buy securities. Please consult an investment professional before investing in anything viewed on the Emerging Growth Conference or on EmergingGrowth.com.If you believe or know of a company that might fit our audience, <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/Tracker?data=biswmavP_w1VMp7Nel7C9D9j1OHwXxFTRybukMNLw3mfp4cLnXEu-KESeF_4-WRfBO2XC9shr8k4h19cKN_PORMM2bC-lqUOhSwmxLe3qv1jkbu7osyk3VYR6BQGYSRF">contact us here.</a>Thank you for your interest in our conference, and we look forward to your participation in future conferences.Contact:Emerging Growth&nbsp; Phone: 1-305-330-1985 Email: Conference@EmergingGrowth.com

Presenting on Emerging Growth Conference 82 Day 2 on May 22; Register to live stream

Others

Regen Biopharma, Inc. is a biotechnology company, which engages in the business of developing regenerative medical applications and advancing novel technologies through pre-clinical and Phase I and II clinical trials. It also focuses on mRNA and small molecule therapies for treating cancer and autoimmune disorders. The company was founded on April 24, 2012 and is headquartered in La Mesa, CA.

RGBPP
Regen Biopharma Pref Shs

Feed

News

Sentiment

Fundamentals

Info

Latest RGBPP News

RGBPPRegen Biopharma Pref Shs